International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic dataDaniel A. Arber, Michael R. Savona, Gabriela Hobbs et al.|Blood|2022Cited by 2.7k
Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant ErythropoietinNicole Casadevall, Patrick Mayeux, J Nataf et al.|New England Journal of Medicine|2002Cited by 1.2k
Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia veraJean‐Jacques Kiladjian, Pierre Fenaux|Blood|2008Cited by 568
A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosisAlessandro M. Vannucchi, H. Kantarjian, Jean‐Jacques Kiladjian et al.|Haematologica|2015Cited by 252
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 studySrđan Verstovšek, Aaron T. Gerds, Alessandro M. Vannucchi et al.|The Lancet|2023Cited by 181